<DOC>
	<DOCNO>NCT02132013</DOCNO>
	<brief_summary>The purpose study evaluate effect efficacy dietary sodium restriction mean new healthcare approach patient chronic kidney disease . The test person intervention group actively support adhere restrict sodium diet structured self-regulation program implement sodium recommendation current guideline .</brief_summary>
	<brief_title>SodiUm Burden Lowered Lifestyle Intervention : Self-Management E-health Technology</brief_title>
	<detailed_description>The intervention entail two group meeting fellow-patients , motivational interviewing , e-coaching ICT-based self-regulation add-on regular care . The intervention consist baseline measurement ( T0 ) , follow preparation phase 2-3 week duration first group meeting . The first group meeting follow action phase second group meet 9-11 week . During action phase , test person stimulate use special self-regulation computer program , monitor dietary sodium intake website receive e-coaching personal coach . Test person control group receive standard care . After 3 month study ( T1 ) , test person visit outpatient clinic measurement data collection . The half year long maintenance phase start timepoint , test person intervention group continue use special website get feedback coach 3 , 4 , 5 , 6 month . After 9 month total study duration ( T2 ) , data collection measurement take place . At timepoint blood 24-hourly urine collect , test person fill questionnaire . The intervention group collect 5 week study additional 24-hourly urine collection ass dietary compliance enable feedback . Cost-efficacy implementation analysis conduct study closure .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Be 18 year old . Have chronic kidney disease ( CKD stage 13 , CKD 4 eGFR low 25 mL/min/1.73m2 , renal transplant recipient . ) Have urinary sodium excretion least last 2 subsequent visit 130 mmol per day , one last urinary sodium excretion 150 mmol per day . Have systolic blood pressure high 135 mmHg , diastolic blood pressure high 85 mmHg wellcontrolled blood pressure treatment antihypertensives include RAASblockade ( ACEinhibitor ARB ) . Sufficient command Dutch language . Access ability use internet . Written informed consent . eGFR &lt; 25 ml/min/1.73m2 anticipate need predialysis workup within time frame study . Unstable disease : define rapid , persistent , progressive renal function loss ( e.g . &gt; 6 mL/min/1.73m2 per year ) , acute , intermittent origin . Blood pressure &gt; 170 mmHg systolic &gt; 100 mmHg diastolic medical treatment Blood pressure &lt; 95 mmHg systolic respond withdrawal antihypertensive . Cardiovascular event ( myocardial infarction , cerebrovascular accident ) &lt; 6 month ago . Renal transplantation &lt; 1 year ago . Medical condition likely interfere completion study ( progressive malignancy debilitate illness ) discretion nephrologist . Every patient participate ESMO study ( regardless whether intervention control ) participate current study . Current participation clinical trial might interfere SUBLIME trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>